ID

34541

Beskrivning

A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics; ODM derived from: https://clinicaltrials.gov/show/NCT02470481

Länk

https://clinicaltrials.gov/show/NCT02470481

Nyckelord

  1. 2019-01-19 2019-01-19 -
  2. 2020-02-11 2020-02-11 - Christian Arras
  3. 2020-03-04 2020-03-04 - Christian Arras
Rättsinnehavare

see on clinicaltrials.gov

Uppladdad den

19 januari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Psoriatic Arthritis NCT02470481

Eligibility Psoriatic Arthritis NCT02470481

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient must be a man or woman aged 18 to 65 years of age, inclusive
Beskrivning

ID.1

Datatyp

boolean

the patient must have an established diagnosis of psoriasis (based upon clinical evidence, and documented medical history [19])
Beskrivning

ID.2

Datatyp

boolean

the patient must be able to read and write in the target language (english, mandarin or korean; or other relevant target languages)
Beskrivning

ID.3

Datatyp

boolean

each patient must sign an informed consent form (icf) indicating that he or she understands the purpose of and procedures required for the study and are willing to participate in the study
Beskrivning

ID.4

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
an established diagnosis of psoriatic arthritis
Beskrivning

ID.5

Datatyp

boolean

ever have received systemic treatment with a disease modifying antirheumatic drug (dmard) for arthritis or spondylitis (inflammatory back pain)
Beskrivning

ID.6

Datatyp

boolean

ever have received systemic treatment with a biologic therapy for psoriasis (including infliximab, golimumab, ustekinumab, adalimumab or etanercept)
Beskrivning

ID.7

Datatyp

boolean

a history of employment in or are currently employed in the healthcare industry; or
Beskrivning

ID.8

Datatyp

boolean

participated in the translation and linguistic validation of the earp questionnaire
Beskrivning

ID.9

Datatyp

boolean

Similar models

Eligibility Psoriatic Arthritis NCT02470481

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patient must be a man or woman aged 18 to 65 years of age, inclusive
boolean
ID.2
Item
the patient must have an established diagnosis of psoriasis (based upon clinical evidence, and documented medical history [19])
boolean
ID.3
Item
the patient must be able to read and write in the target language (english, mandarin or korean; or other relevant target languages)
boolean
ID.4
Item
each patient must sign an informed consent form (icf) indicating that he or she understands the purpose of and procedures required for the study and are willing to participate in the study
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
an established diagnosis of psoriatic arthritis
boolean
ID.6
Item
ever have received systemic treatment with a disease modifying antirheumatic drug (dmard) for arthritis or spondylitis (inflammatory back pain)
boolean
ID.7
Item
ever have received systemic treatment with a biologic therapy for psoriasis (including infliximab, golimumab, ustekinumab, adalimumab or etanercept)
boolean
ID.8
Item
a history of employment in or are currently employed in the healthcare industry; or
boolean
ID.9
Item
participated in the translation and linguistic validation of the earp questionnaire
boolean

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial